- Ongoing, recruitingTherapeutic exploratory (Phase II)
IMLIFIDASE IN LIVING DONOR RENAL TRANSPLANTATION: HIGHLY SENSITIZED RECIPIENTS (LIVEDES STUDY)
This study looks at a new treatment called imlifidase for people who need a kidney transplant but have strong antibodies that make it hard to find a match. It aims to see if imlifidase can help these patients receive a life-changing kidney from a living donor.
For: kidney trasplantSpain - RecruitingPHASE2
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
This study looks at a new medicine called Imlifidase for children aged 1 to 17 needing a kidney transplant. It helps prepare their body for a new kidney if they've struggled with previous treatments to find a match.
For: Kidney Transplantation in Highly Sensitized PatientsFinland · France · Spain